zanamivir has been researched along with Asthma in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Del Mar, CB; Doshi, P; Hama, R; Heneghan, CJ; Howick, J; Jefferson, T; Jones, MA; Mahtani, KR; Nunan, D; Onakpoya, I; Spencer, EA; Thompson, MJ | 1 |
Harnden, A; Heneghan, C; Mant, D; Perera, R; Shun-Shin, M; Thompson, M | 1 |
Watanabe, A | 1 |
Pegram, PS; Williamson, JC | 1 |
Bye, A; Cass, LM; Gunawardena, KA; Macmahon, MM | 1 |
Stephenson, J | 1 |
3 review(s) available for zanamivir and Asthma
Article | Year |
---|---|
Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data.
Topics: Adult; Antiviral Agents; Asthma; Child; Dose-Response Relationship, Drug; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Neuraminidase; Oseltamivir; Randomized Controlled Trials as Topic; Zanamivir | 2016 |
Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials.
Topics: Anti-Bacterial Agents; Antiviral Agents; Asthma; Bias; Child; Child, Preschool; Enzyme Inhibitors; Humans; Infant; Influenza, Human; Neuraminidase; Oseltamivir; Otitis Media; Randomized Controlled Trials as Topic; Risk Factors; Zanamivir | 2009 |
Neuraminidase inhibitors in patients with underlying airways disease.
Topics: Acetamides; Amantadine; Antiviral Agents; Asthma; Bronchial Spasm; Comorbidity; Guanidines; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Product Surveillance, Postmarketing; Pulmonary Disease, Chronic Obstructive; Pyrans; Rimantadine; Risk Factors; Sialic Acids; Zanamivir | 2002 |
2 trial(s) available for zanamivir and Asthma
Article | Year |
---|---|
A randomized double-blind controlled study of laninamivir compared with oseltamivir for the treatment of influenza in patients with chronic respiratory diseases.
Topics: Adult; Aged; Antiviral Agents; Asthma; Chronic Disease; Double-Blind Method; Enzyme Inhibitors; Female; Guanidines; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Neuraminidase; Oseltamivir; Pyrans; Sialic Acids; Treatment Outcome; Zanamivir | 2013 |
Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir.
Topics: Administration, Inhalation; Adult; Asthma; Cross-Over Studies; Double-Blind Method; Enzyme Inhibitors; Female; Forced Expiratory Volume; Guanidines; Humans; Male; Middle Aged; Neuraminidase; Peak Expiratory Flow Rate; Pyrans; Sialic Acids; Vital Capacity; Zanamivir | 2000 |
1 other study(ies) available for zanamivir and Asthma
Article | Year |
---|---|
Study allays therapy concern, finds new flu drug safe for patients with asthma, COPD.
Topics: Antiviral Agents; Asthma; Guanidines; Humans; Influenza, Human; Lung Diseases, Obstructive; Pyrans; Risk; Sialic Acids; Zanamivir | 2000 |